It works by reducing appetite, improving blood sugar, and lowering risk of cardiovascular disease (heart disease, heart attack, and stroke)
After nonfatal myocardial infarction or stroke, initiation of a GLP-1 receptor agonist was linked to reduced risk for all-cause and CV-related mortality in patients with diabetes, researchers reported
Practical Implications for Patients For patients suffering from back pain, the potential benefits of weight loss through semaglutide are promising
Tirzepatide's dual-receptor activation may cause slightly more GI effects during dose escalation in some patients
This is an enormous motivator for the severely obese, or anyone who wants to lose 20% or more of their bodyweight for any reason, including rejoining the body elite. However, these two different medically authorized solutions currently differ a lot in their cost to consumers and ease of qualification to use